Order Entry
ContactUsLinkComponent
Anti-Dupilumab Mouse Monoclonal Antibody [clone: 6C9]
Anti-Dupilumab Mouse Monoclonal Antibody [clone: 6C9]
# de catalogue 77007-612
Fournisseur:  Genscript
New Product
Anti-Dupilumab Mouse Monoclonal Antibody [clone: 6C9]
# de catalogue 77007-612
Fournisseur:  Genscript
New Product
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Spécifications

  • Antigen name:
    Dupilumab
  • Clonality:
    Monoclonal
  • Clone:
    6C9
  • Host:
    Mouse
  • Isotype:
    IgG1 kappa
  • Conjugation:
    Unconjugated
  • ELISA:
    Yes
  • Size:
    40 μg
  • Cross adsorption:
    No
  • Form:
    Lyophilized
  • Storage buffer:
    This product is lyophilized with PBS, pH 7.2, containing 0.02% sodium azide
  • Storage temperature:
    The lyophilized product remains stable up to 1 year at −20 °C from date of receipt. Upon reconstitution, it can be stored for 2 - 3 weeks at 2 - 8 °C or for up to 12 months at −20 °C or below. Avoid repeated freezing and thawing cycles
  • Concentration:
    Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml
  • Immunogen:
    Dupilumab
  • Packaging:
    Vial

Spécifications

A propos de cet article

Dupilumab with trade name dupixent, is an FDA-approved drug for the treatment of patients aged six years and older with moderate-to-severe atopic dermatitis. It is a human monoclonal antibody. Dupilumab binds to the interleukin-4 receptor alpha (IL-4R alpha) subunit shared by the interleukin (IL)-4 and IL-13 receptor complexes, thereby inhibiting IL-4 and IL-13 signaling. Anti-Dupilumab Antibody (6C9), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with dupilumab.

  • High specificity
  • High affinity
  • High stability

GenScript has developed a broad range of off-the-shelf anti-idiotype antibodies against blockbuster drugs to help accelerate your research of biosimilars.

Type:
Antigen: Dupilumab
Clonality: Monoclonal
Clone: 6C9
Conjugation: Unconjugated
Epitope:
Host: Mouse
Isotype: IgG1 kappa
Reactivity:

Customers Who Bought This Also Bought